维普中文期刊产品整合服务
31篇 您的检索式:作者名="Abernethy DR"
    题名 作者 年代 出处 被引量
1Structure-functional diversity of human L-type Ca^2 + channel: perspectives for new pharmacological targets显示文摘Abernethy DR Soldatov NM 2002J Pharmacol Exp Ther2002,300,:1
2Effect of obesity on the pharmacokinetics of drugs in humans 显示文摘Hanley M J Abernethy DR Greenblatt DJ 2010Clin Pharmacokinet2010,49,2:1
3Pharmacokinetics and clinical effectiveness of methylpenidate 显示文摘Kimki HC Cross JT Abernethy DR 1999Clin Pharmacokinet1999,37,:1
4Calcium-antagonist drugs 显示文摘Abernethy DR Schwartz JB 1999N Engl J Med1999,341,19:1
5Technical De- siderata for the Integration of Genomic Data into Electronic Health Records 显示文摘Masys DR Jarvik GP Abernethy NF 2012Journal of Biomedical Informatics2012,,45:1
6Effect of age,gender,and obesity on midazolam kinetics显示文摘Greenblatt DJ Abernethy DR Locniskar A 1984Anesthesiology1984,61,1:1
7Effect of age, gender, and obesity on midazolam kinetics显示文摘Greenblatt DJ Abernethy DR Locniskar A 1984Anesthesiology1984,61,1:1
8Effect of obesity on the pharmacokinetics of drugs in humans显示文摘Hanley M J Abernethy DR Greenblatt DJ 2010Clin pharmacokinet2010,49,:1
9Digoxin disposition in o-besity:clinical pharmacokinetic investigation显示文摘Abernethy DR Greenblatt DJ Smith TW 1981Am Heart J1981,102,:1
10Minoxidil analysis in human plasma using HPLC with electrochemical detection显示文摘 Abernethy DR Sadhukhan M 1986J Chromatogr1986,381,1:1
11Pharmacokinetics and clinical effectiveness of methylphenidate 显示文摘Kimki HC Cross JT Abernethy DR 1999Clin Pharmacokinet1999,37,:1
12Pharmacological properties of combination therapies for hypertension显示文摘Abernethy DR 1997Am J Hypertens1997,10,3:1
13Effect of Obesity on the pharmacokinetics of drugs in humans显示文摘Hanley MJ Abernethy DR Greenblatt DJ 2010Clin Pharmacokinet2010,49,2:1
14Verapamil decreases lymphocyte protein kinase C activity in humans 显示文摘DePetrillo PB Abernethy DR Wainer IW 1994Clin Pharmacol Ther1994,55,:1
15Interaction of cimetidine with oxazepam,lorazepam,and flurazepam显示文摘 Abernethy DR Koepke HH 1984I Clin Pharmacol1984,24,4:1
16Pediatric dose selection 显示文摘Abernethy DR Burekart GJ 2009Clin Pharmacol Thera2009,87,:1
17Pharmacological properties of combination therapies for hypertension显示文摘Abernethy DR 1997Am J Hypertens1997,10,3:1
18Lorazepam analysis using liquid chromatography: improved sensitivity for single-dose pharmacokinetic studies显示文摘Egan JM Abernethy DR 1986J Chromatogr1986,380,1:1
19Calcium-antagonist drugs显示文摘Abernethy DR Schwartz JB 1999N Engl J Med1999,341,:1
20Doxepin-cimetidine interaction:increased doxepin bioavailability during cimetidine treatment显示文摘 Todd EL 1986J Clin Psychopharmacol1986,6,1:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费